These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 24162384

  • 1. Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.
    West KL, Cardona DM, Su Z, Puri PK.
    Am J Dermatopathol; 2014 May; 36(5):414-9. PubMed ID: 24162384
    [Abstract] [Full Text] [Related]

  • 2. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
    Kim HJ, Lee JY, Kim SH, Seo YJ, Lee JH, Park JK, Kim MH, Cinn YW, Cho KH, Yoon TY.
    Br J Dermatol; 2007 Aug; 157(2):319-24. PubMed ID: 17596171
    [Abstract] [Full Text] [Related]

  • 3. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
    Kahn HJ, Fekete E, From L.
    Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Differences of the molecular phenotypes and the histogenesis between dermatofibroma and dermatofibrosarcoma protuberans].
    Xiong Y, Guo H, Zhang S, Zhang B, Li T.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug 18; 40(4):395-400. PubMed ID: 18677387
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.
    Goldblum JR, Tuthill RJ.
    Am J Dermatopathol; 1997 Apr 18; 19(2):147-53. PubMed ID: 9129699
    [Abstract] [Full Text] [Related]

  • 12. IGFBP7, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans.
    Li J, Yu Y, Yang Y, Wang L, Cao J, Liang X, Xiao X, Tu Y, Chen H.
    J Eur Acad Dermatol Venereol; 2012 Mar 18; 26(3):382-5. PubMed ID: 21492256
    [Abstract] [Full Text] [Related]

  • 13. CD99 expression in dermatofibrosarcoma protuberans and dermatofibroma.
    Kazlouskaya V, Malhotra S, Kabigting FD, Lal K, Elston DM.
    Am J Dermatopathol; 2014 May 18; 36(5):392-6. PubMed ID: 24247571
    [Abstract] [Full Text] [Related]

  • 14. S100A6 expression in fibrohistiocytic lesions.
    Fullen DR, Reed JA, Finnerty B, McNutt NS.
    J Cutan Pathol; 2001 May 18; 28(5):229-34. PubMed ID: 11401666
    [Abstract] [Full Text] [Related]

  • 15. Expression of MMP-2, MMP-9 and MMP-11 in dermatofibroma and dermatofibrosarcoma protuberans.
    Chen YT, Chen WT, Huang WT, Wu CC, Chai CY.
    Kaohsiung J Med Sci; 2012 Oct 18; 28(10):545-9. PubMed ID: 23089320
    [Abstract] [Full Text] [Related]

  • 16. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans?
    Horenstein MG, Prieto VG, Nuckols JD, Burchette JL, Shea CR.
    Am J Surg Pathol; 2000 Jul 18; 24(7):996-1003. PubMed ID: 10895822
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin.
    Wang WL, Patel KU, Coleman NM, Smith-Zagone MJ, Ivan D, Reed JA, López-Terrada D, Lazar AJ, Prieto VG.
    Am J Dermatopathol; 2010 Apr 18; 32(2):149-53. PubMed ID: 19940748
    [Abstract] [Full Text] [Related]

  • 19. Dermatofibrosarcoma protuberans: a tumour of nestin-positive cutaneous mesenchymal stem cells?
    Sellheyer K, Nelson P, Krahl D.
    Br J Dermatol; 2009 Dec 18; 161(6):1317-22. PubMed ID: 19659472
    [Abstract] [Full Text] [Related]

  • 20. The pathological distinction between "deep penetrating" dermatofibroma and dermatofibrosarcoma protuberans.
    Wick MR, Ritter JH, Lind AC, Swanson PE.
    Semin Cutan Med Surg; 1999 Mar 18; 18(1):91-8. PubMed ID: 10188848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.